SHASUNPHAR

Shasun Pharmaceuticals Limited has submitted to the Exchange vide letter dated June 10, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sequent Scientific Limited has submitted to the Exchange vide letter dated June 9, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange, vide letter dated June 03, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Morgan Stanley Asia (Singapore) Pte has submitted to the Exchange vide letter dated June 3, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Jitesh Devendra has submitted to the Exchange, vide letter dated January 19, 2015 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange vide letter dated January 20, 2015 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange, vide letter dated December 31, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange, vide letter dated December 31, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 2011.

Ambematha Securities has submitted to the Exchange, vide letter dated December 31, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Chayadeep Properties Private Limited & Pronomz Ventures LLP have submitted to the Exchange, vide letter dated December 31, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 2011.

Morgan Stanley Asia (Singapore) Pte. has submitted to the Exchange vide letter dated September 04, 2014 a copy of disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 2011.

Shasun Pharmaceuticals Limited has informed the Exchange that the Nomination & Remuneration Committee of the Company at its meeting held on August 06, 2014 had granted 2,23,000 stock options under Employee Stock Option Plan 2012 to the employees exercisable into same number of Equity shares of the Company.

Devendra Estates Pvt Ltd has submitted to the Exchange vide letter dated July 16, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange vide letter dated June 19, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Morgan Stanley Asia (Singapore) Pte has submitted to the Exchange, vide letter dated June 19, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sequent Scientific Limited has submitted to the Exchange, vide letter dated June 03, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sequent Scientific Limited has submitted to the Exchange vide letter dated June 03, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange vide letter dated May 22, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sundaram Asset Management Co Ltd has submitted to the Exchange vide letter dated May 20, 2014 a copy of Disclosure in terms of Regulation 29 (2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D Sajjan has submitted to the Exchange vide letter dated April 23, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D Jitesh has submitted to the Exchange, vide letter dated April 12, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D Sjjan has submitted to the Exchange vide letter dated March 05, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

V Leela has submitted to the Exchange vide letter dated March 03, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange vide letter dated October 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Easyaccess Financial Services Limited has submitted to the Exchange vide letter dated October 18, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange, vide letter dated June 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Cholamandalam Investment and Finance Company Ltd has submitted to the Exchange vide letter dated June 20, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D Sajjan has submitted to the Exchange vide its letter dated May 15, 2013 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

D Sajjan has submitted to the Exchange vide its letter dated February 15, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D. Sajjan has submitted to the Exchange vide letter dated February 08, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange, vide letter dated December 24, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sundaram Asset Management Company Limited has submitted to the Exchange vide letter dated December 24, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D Sajjan has submitted to the Exchange vide its letter dated November 15, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

V. Leela has submitted to the Exchange vide letter dated September 30, 2012 a copy of disclosure under Regulation 31(1), 31(2),31(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Devendra Estates Private Limited has submitted to the Exchange vide letter dated September 30, 2012 a copy of disclosure under Regulation 31(1), 31(2),31(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D. Sajjan has submitted to the Exchange vide letter dated September 06, 2012 a copy of disclosure under Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sundaram Asset Management Company Limited has submitted to the Exchange vide letter dated August 21, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shasun Pharmaceuticals Limited has submitted to the Exchange vide its letter dated August 13, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Citibank N.A. has submitted to the Exchange vide its letter dated August 10, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

S. Devendra has submitted to the Exchange vide letter dated July 26, 2012 a copy of disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Caduceus Asia Mauritius Limited has submitted to the Exchange vide its letter dated March 30, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Cholamandalam Investment and Finance Company Limited has submitted to the Exchange a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

V.Leela has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1),31(2),31(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

A. Deepak has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Taru Mayur has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Usha Abhaykumar has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

S. Abhayakumar has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Citibank N.A. has submitted to the Exchange a copy of disclosure under regulations 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Citibank N.A. has submitted to the Exchange a copy of disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Shasun Chemicals And Drugs Ltd. has informed the Exchange that SBI Mutual Fund have acquired 27,878 shares aggregating to 0.30% of the total paid up capital of Shasun Chemicals & Drugs Ltd. on June 15, 2005. The mode of acquisition is through Open Market and the shareholding of SBI Mutual Fund after the said acquisition is 460,316 shares aggregating to 5.03% of the total paid up capital of Shasun Chemicals & Drugs Ltd.